Free Trial
LON:SPH

Sinclair Pharma (SPH) Share Price, News & Analysis

Sinclair Pharma logo

About Sinclair Pharma Stock (LON:SPH)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
31.80
31.80
52-Week Range
N/A
Volume
373,221 shs
Average Volume
3.30 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sinclair Pharma plc, a specialty pharmaceutical company, engages in the manufacture, commercialization, and sale of dermatological products worldwide. It provides Silhouette Soft, a resorbable poly-L-lactic acid(PLLA)/PLGA suture with bi-directional resorbable cones for skin repositioning and tightening; and Ellansé, which offers dermal fillers. The company also provides Perfectha for wrinkle correction, facial contouring, and volume restoration; and Sculptra designed to stimulate collagen growth. It serves healthcare providers and plastic surgeons. The company was formerly known as Sinclair IS Pharma plc and changed its name to Sinclair Pharma plc in December 2015. Sinclair Pharma plc was founded in 1971 and is headquartered in London, the United Kingdom.

Receive SPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sinclair Pharma and its competitors with MarketBeat's FREE daily newsletter.

SPH Stock News Headlines

Sinclair Is Pharma Plc (SPH)
Trump Quietly Planning $15 Trillion Crypto Shocker
Most investors are still unaware, but I believe a new White House action may have quietly opened the floodgates for a $15 trillion crypto surge. My latest crypto playbook reveals the coin I’m most bullish on—including the name, ticker, and why I’m investing personal capital into it.
Cheryl Sinclair
Dr. Robert Sinclair
See More Headlines

SPH Stock Analysis - Frequently Asked Questions

Shares of SPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sinclair Pharma investors own include Vectura Group (VEC), Bristol-Myers Squibb (BMY), Energy Transfer (ET), Hikma Pharmaceuticals (HIK), Jack in the Box (JACK), Merck & Co., Inc. (MRK) and Transocean (RIG).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - Major
Sub-Industry
N/A
Current Symbol
LON:SPH
CIK
N/A
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (LON:SPH) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners